Vaccine clinical trials to treat and potentially prevent type 1 diabetes 28 April 2021 An oral vaccine that could treat or potentially prevent type 1 diabetes is in clinical trials at the University of Queensland. Associate Professor Emma Hamilton-Williams hopes the research will end the lifelong dependency on insulin. With the support of the Diabetes Australia Research Program researchers are aiming to create a vaccine that can re-educate the t-cells in the immune system to stop the pathogenic process that leads them to destroy the insulin-producing cells in the pancreas. You can watch the video here:
Blog 18 November 2026 Make a splash: Water exercise for diabetes As the weather warms up, it can be less enticing to go for that walk or bike ride, so why... Continue Reading
Media releases 18 November 2026 Foundayo approval a welcome addition to GLP-1 treatment options Diabetes Australia has welcomed the TGA approval of Foundayo (orforglipron), a new oral GLP-1 receptor agonist for the management of type 2 diabetes and chronic weight management in eligible adults. Continue Reading
Blog 18 November 2026 Five days of easier meal decisions Discover five days of realistic meal ideas designed to help you enjoy a variety of foods, save time in the kitchen, and make nutritious choices with less stress and planning. Continue Reading